Department of Cardiology, Clinical Sciences, Lund University, 221 85, Lund, Sweden.
Department of Medicine, Sahlgrenska University Hospital, Mölndal, Sweden.
BMC Cardiovasc Disord. 2019 Aug 13;19(1):195. doi: 10.1186/s12872-019-1169-1.
In patients with cardiac resynchronization therapy (CRT), atrial fibrillation (AF) is associated with an unfavorable outcome and may cause loss of biventricular pacing (BivP). An effective delivery of BivP of more than 98% of all ventricular beats has been shown to be a major determinant of CRT-success.
At a Swedish tertiary referral center, data was retrospectively obtained from patient registers, medical records and preoperative electrocardiograms. Data regarding AF and BivP during the first year of follow-up was assessed from CRT-device interrogations. No intra-cardiac electrograms were studied. Kaplan-Meier curves and Cox-regression analyses adjusted for age, etiology of heart failure, left ventricular ejection fraction, left bundle branch block and NYHA class were performed to assess the impact of AF and BivP on the risk of death or heart transplantation (HTx) at 10-years of follow-up.
Preoperative AF-history was found in 54% of the 379 included patients and was associated with, but did not independently predict death or HTx. The one-year incidence of new device-detected AF was 22% but not associated with poorer prognosis. At one-year, AF-history and BivP≤98%, was associated with a higher risk of death or HTx compared to patients without AF (HR 1.9, 95%CI 1.2-3.0, p = 0.005) whereas AF and BivP> 98% was not (HR 1.4, 95%CI 0.9-2.3, p = 0.14).
In CRT-recipients, AF-history is common and associated with poor outcome. AF-history does not independently predict mortality and is probably only a marker of a more severe underlying disease. BivP≤98% during first-year of CRT-treatment independently predicts poor outcome thus further supporting the use of 98% threshold of BivP, which should be attained to maximize the benefits of CRT.
在接受心脏再同步治疗(CRT)的患者中,心房颤动(AF)与不良预后相关,并可能导致双心室起搏(BivP)丧失。已证明超过 98%的心室搏动有效传递 BivP 是 CRT 成功的主要决定因素。
在瑞典的一家三级转诊中心,从患者登记处、病历和术前心电图中回顾性获得数据。通过 CRT 设备询问评估了随访第一年期间的 AF 和 BivP 数据。未研究心内电图。进行 Kaplan-Meier 曲线和 Cox 回归分析,调整年龄、心力衰竭病因、左心室射血分数、左束支传导阻滞和 NYHA 分级,以评估 AF 和 BivP 对 10 年随访期间死亡或心脏移植(HTx)风险的影响。
在 379 名纳入患者中,54%的患者有术前 AF 病史,与死亡或 HTx 相关,但不能独立预测。新发设备检测到的 AF 的一年发生率为 22%,但与预后较差无关。在一年时,与无 AF 患者相比,AF 病史和 BivP≤98%与更高的死亡或 HTx 风险相关(HR 1.9,95%CI 1.2-3.0,p=0.005),而 AF 和 BivP>98% 则不然(HR 1.4,95%CI 0.9-2.3,p=0.14)。
在 CRT 接受者中,AF 病史很常见,并与不良预后相关。AF 病史不能独立预测死亡率,可能只是更严重基础疾病的标志物。CRT 治疗第一年的 BivP≤98%独立预测不良预后,因此进一步支持使用 98%的 BivP 阈值,这应该达到以最大化 CRT 的益处。